FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma

Molecular Biology of the Cell

Volumn 23, Issue 11, 2012, Pages 2226-2234

  Geiger, Kathrin ^a   Hagenbuchner, Judith ^a,b   Rupp, Martina ^a,b   Fiegl, Heidi ^b   Sergi, Consolato ^c,d   Meister, Bernhard ^b   Kiechl Kohlendorfer, Ursula ^b   Müller, Thomas ^b   Ausserlechner, Michael J ^a,b   Obexer, Petra ^a,b  

^a TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ATM PROTEIN; CASPASE 8; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY DNA SEQUENCE;

APOPTOSIS; AZACITIDINE; BASE SEQUENCE; CASPASE 8; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA METHYLATION; DNA-BINDING PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; ENZYME INDUCTION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEK293 CELLS; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEINS;

EID: 84861702434     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-06-0535     Document Type: Article

References (38)

1. Arden KC (2008). FOXO animal models reveal a variety of diverse roles for FOXO transcription factors. Oncogene 27, 2345-2350.
2. Banelli B et al. (2002). Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med 8, 1333-1335. (Pubitemid 36019400)
3. Barbero S et al. (2009). Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res 69, 3755-3763.
4. Burgering BM, Kops GJ (2002). Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27, 352-360. (Pubitemid 34756518)
5. Calnan DR, Brunet A (2008). The FoxO code. Oncogene 27, 2276-2288. (Pubitemid 351501779)
6. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000). Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10, 1201-1204.
7. Ditch S, Paull TT (2012). The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem Sci 37, 15-22.
8. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28, E32.
9. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ikegaki N, Brodeur GM (2000). Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med Pediatr Oncol 35, 603-607.
10. Essers MA, Weijzen S, Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM (2004). FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23, 4802-4812. (Pubitemid 40069710)
11. Fernandes ND, Sun Y, Price BD (2007). Activation of the kinase activity of ATM by retinoic acid is required for CREB-dependent differentiation of neuroblastoma cells. J Biol Chem 282, 16577-16584. (Pubitemid 47100398)
12. Fulda S, Debatin KM (2002). IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21, 2295-2308. (Pubitemid 34407289)
13. Fulda S, Kufer MU, Meyer E, Van Valen F, Dockhorn-Dworniczak B, Debatin KM (2001). Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20, 5865-5877. (Pubitemid 32937956)
14. Fulda S, Poremba C, Berwanger B, Hacker S, Eilers M, Christiansen H, Hero B, Debatin KM (2006). Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma. Cancer Res 66, 10016-10023. (Pubitemid 44672054)
15. Gross DN, van den Heuvel AP, Birnbaum MJ (2008). The role of FoxO in the regulation of metabolism. Oncogene 27, 2320-2336. (Pubitemid 351501783)
16. Hagenbuchner J, Ausserlechner MJ, Porto V, David R, Meister B, Bodner M, Villunger A, Geiger K, Obexer P (2010). The anti-apoptotic protein CL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J Biol Chem 285, 6904-6912.
17. Hagenbuchner J, Kuznetsov AV, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012). FOXO3-induced reactive oxygen species are regulated by BCL2L11/Bim and SESN3. J Cell Sci 125, 1191-1203.
18. Ho KK, Myatt SS, Lam EW (2008). Many forks in the path: cycling with FoxO. Oncogene 27, 2300-2311. (Pubitemid 351501781)
19. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N (2000). Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60, 4315-4319. (Pubitemid 32103601)
20. Jiang M, Zhu K, Grenet J, Lahti JM (2008). Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. Biochim Biophys Acta 1783, 1055-1067.
21. Lehtinen MK et al. (2006). A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001. (Pubitemid 43795191)
22. Li Z, Jaboin J, Dennis PA, Thiele CJ (2005). Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res 65, 2070-2075. (Pubitemid 40490110)
23. Narath R, Lorch T, Greulich-Bode KM, Boukamp P, Ambros PF (2005). Automatic telomere length measurements in interphase nuclei by IQ-FISH. Cytometry A 68, 113-120. (Pubitemid 41705204)
24. Obexer P, Geiger K, Ambros PF, Meister B, Ausserlechner MJ (2007). FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 14, 534-547.
25. Obexer P, Hagenbuchner J, Unterkircher T, Sachsenmaier N, Seifarth C, Bock G, Porto V, Geiger K, Ausserlechner M (2009). Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell 20, 2041-2048.
26. Opel D, Poremba C, Simon T, Debatin KM, Fulda S (2007). Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 67, 735-745. (Pubitemid 46192214)
27. Palii SS, Van Emburgh BO, Sankpal UT, Brown KD, Robertson KD (2008). DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol 28, 752-771.
28. Park JR, Eggert A, Caron H (2008). Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55, 97-120. (Pubitemid 351173188)
29. Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, Huang Y, Dawson TM, Snyder SH, Ginty DD (2006). A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 21, 283-294. (Pubitemid 43099943)
30. Schwab TS, Madison BB, Grauman AR, Feldman EL (2005). Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells. Apoptosis 10, 831-840. (Pubitemid 41187081)
31. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA (2006). Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439, 95-99. (Pubitemid 43053635)
32. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y (2005). JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170, 295-304. (Pubitemid 41043811)
33. Teitz T et al. (2000). Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6, 529-535. (Pubitemid 30305902)
34. Tekautz TM, Zhu K, Grenet J, Kaushal D, Kidd VJ, Lahti JM (2006). Evaluation of IFN-gamma effects on apoptosis and gene expression in neuroblastoma - preclinical studies. Biochim Biophys Acta 1763, 1000-1010. (Pubitemid 44488565)
35. Tsai WB, Chung YM, Takahashi Y, Xu Z, Hu MC (2008). Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 10, 460-467.
36. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW (2005). Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33, 6823-6836. (Pubitemid 41830488)
37. Yalcin S et al. (2008). Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 283, 25692-25705.
38. Yamamoto K et al. (1998). Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16, 1265-1269. (Pubitemid 28175738)